Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03677375 · ClinicalTrials.gov registry record · NA
Hemodilution Validation of INVSENSOR00026
A NA study, sponsored by Masimo Corporation.
- Completed
- Registry status
- NA
- Development phase
- 173
- Enrollment target
NCT03677375 is a NA study that has completed, run by Masimo Corporation. The registered enrollment target is 173 participants.
The verdict
NCT03677375, a NA study, has completed, sponsored by Masimo Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 173 participants
- Enrollment target
Study Summary
In this study, the concentration of hemoglobin within the subject's blood will be reduced in a controlled manner by administering fluids intravenously. The accuracy of a noninvasive hemoglobin sensor will be assessed by comparison to hemoglobin measurements from a laboratory analyzer.
Interventions
- DEVICE INVSENSOR00026
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 173 participants |
| Start Date | 2018-09-04 |
| Est. Completion | 2019-02-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03677375
The ClinicalTrials.gov registry entry for NCT03677375 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 173 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Masimo Corporation, which has 96 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which INVSENSOR00026 is the first listed.
NCT03677375 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03677375 about?
NCT03677375 is a clinical study titled "Hemodilution Validation of INVSENSOR00026". In this study, the concentration of hemoglobin within the subject's blood will be reduced in a controlled manner by administering fluids intravenously. The accuracy of a noninvasive hemoglobin sensor will be assessed by comparison to hemoglobin measurements from a laboratory analyzer.
What is the current status of trial NCT03677375?
This trial is currently completed. It is a NA study. The enrollment target is 173 participants. The study started on 2018-09-04. Estimated completion is 2019-02-04.
What interventions are being tested in trial NCT03677375?
The interventions under investigation include: INVSENSOR00026 (DEVICE).
Who is sponsoring clinical trial NCT03677375?
This trial is sponsored by Masimo Corporation, which has 96 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.